...
首页> 外文期刊>Orthopedics >Osseous Metastatic Disease to the Hands and Feet
【24h】

Osseous Metastatic Disease to the Hands and Feet

机译:骨质转移性疾病到手和脚

获取原文
获取原文并翻译 | 示例
           

摘要

Osseous metastas to the hands and feet arc exceedingly rare. Historically, the most common primary cancer observed has been lung carcinoma, treated either nonoperatively or with amputation. the aim of this study was to describe the clinical characteristics associated with acrometastases. This was a retrospective review of 28 patients with histologically proven osseous metastatic disease to the hands and feet. Variables recorded included primary cancer histology, age at diagnosis of primary and acrornetastast location of acrometastases, burden of disease, treatment, and age at death: Kaplan-Meier curves were used to estimate survival, and log-rank tests were used for comparison. The median age at acrometastases diagnosis was 61.5 years, and the most common associated primary cancer was lung carcinoma (n=9) Sixteen patients had acrornetastascs to the toot, and 12 had acrometastases to the hand. In the toot most acrometastases were located in the tarsal bones tn (n=11), followed by the metatarsals (n=4) and the phalanges (n=3). In the hand, most were in the metacarpals and the phalanges (n=6 each), and 2 were in the carpals. The most common treatment was resection or curettage only (n =7). The median duration of survival after acrometastases diagnosis was 9.7 months. Despite advances in cancer treatment and shifting patterns of metastatic disease, there has been little change in the distribution of primary malignancies responsible for acrometastases, with lung carcinoma remaining the most common. Ablative procedures are rarely required, with limb-salvage interventions predominating.
机译:骨质的metastas到双手和脚弧非常罕见。从历史上看,观察到的最常见的原发性癌症已经是肺癌,无论是无手术或截肢。本研究的目的是描述与静态酶相关的临床特征。这是对28例组织学证明骨质转移性疾病的回顾性审查到手脚。记录的变量包括原发性癌症组织学,诊断的年龄和inrornetastast的静脉静力诱导,疾病负担,治疗和死亡年龄:用于估计存活率的Kaplan-Meier曲线,并且使用对数级测试进行比较。静力计诊断的中位年龄为61.5岁,而最常见的相关原发癌症是肺癌(n = 9)16名患者患有Toot的inrornetastics,并且手中有12个诱导酶。在小卵巢中,大多数静脉凝固酶位于塔形骨骨TN(n = 11)中,然后是跖骨(n = 4)和蝶形(n = 3)。在手中,大多数是在术中,骨头(每个n = 6)和2位在腕骨中。最常见的治疗方法仅切除或刮除(n = 7)。静管诱导后生存的中值持续时间为9.7个月。尽管癌症治疗和转移性疾病的转化模式进展,但原发性恶性肿瘤的分布几乎没有变化,负责静力酶,肺癌仍然是最常见的。偏心的程序很少需要偏移肢体救助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号